Entakapon øger biotilgængeligheden af levodopa for standardformuleringer af levodopa/ benserazid 5– 10% mere end for standardformuleringer af levodopa/ carbidopa.
Entacapone increases the bioavailability of levodopa from standard levodopa/ benserazide preparations 5-10% more than from standard levodopa/ carbidopa preparations.